Skip to main content
Clinical Trials/NCT03906591
NCT03906591
Unknown
Not Applicable

Evaluation Of Crestal Bone Level After Alveolar Bone Augmentation of Atrophied Posterior Mandibular Region Using Allogenic Bone Rings Vs. Autogenous Bone Rings With Simultaneous Dental Implant Placement (A Randomized Controlled Clinical Trial)

Cairo University0 sites28 target enrollmentOctober 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Allogenic Bone Ring
Sponsor
Cairo University
Enrollment
28
Primary Endpoint
change in crestal bone height
Last Updated
7 years ago

Overview

Brief Summary

This trial is aiming to answer a question whether in Patients with severely atrophied, distal mandibular regions, the use of allogenic bone rings with simultaneous dental implants, compared to autogenous bone rings, give successful clinical and radiographic outcomes without donor site morbidity

Registry
clinicaltrials.gov
Start Date
October 2019
End Date
February 2023
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alaa El-Deen Ragab Mahmoud

principal investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Medically free form any systemic diseases that contraindicate the surgical procedures or affect predictable outcomes and non-smoker subjects.
  • Atrophic mandibular distal region requiring vertical augmentation.
  • Good oral hygiene and healthy keratinized mucosa.

Exclusion Criteria

  • Presence of acute dentoalveolar infection or any pathologic lesions.
  • Totally edentulous patients and patients requiring massive reconstruction and augmentation procedures.
  • Patients with history of previously failed augmentation procedures, or failed implant placement at the intended augmentation region.

Outcomes

Primary Outcomes

change in crestal bone height

Time Frame: at 6 months

cone beam computed tomography will be used to measure bone height in millimeters

Secondary Outcomes

  • implant loss(after 1 week, 6 months and after 9 months)
  • graft failure(after 1 week, 6 months and after 9 months)

Similar Trials